Loading Shopping Cart Items...
FREE FOR MEMBERS!
Description:
Lyme disease is the most common vector-borne infection in the northern hemisphere, where it poses an escalating threat to the health of Canadians. Despite over four decades of investigation into the disease and the causative pathogen, Borrelia burgdorferi, fundamental knowledge gaps remain that impact diagnostic testing, treatment, and outcome, and render Lyme one of the most polarized and politicized diseases of the 21st century. This session will explore the disease from the perspectives of clinical and laboratory medicine, including the challenges and opportunities in the research and development space.
Date: June 8, 2022
Time: 12pm – 1pm (ET)
At the end of this session you will be able to:
Speaker: Melanie Wills (Ph.D.); Director, G. Magnotta Lyme Disease Research Lab
Melanie completed her doctoral degree in molecular and cellular biology at the University of Guelph, investigating biochemical “wiring” in cells that cause them to misbehave and give rise to diseases like cancer. In 2017, she was appointed as the inaugural Director of the G. Magnotta Lyme Disease Research Lab at the University of Guelph, which she developed from the ground up with a mandate to improve diagnostic testing and treatment. As a chronic disease sufferer herself, Melanie is passionate about innovation that will provide better outcomes for patients.
PEP hours: 1.0
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.
Loading Shopping Cart Items...